Table 1

Patient characteristics

Patient no.Binet stageTreatment statusIgVH mutational status*ZAP-70 expressionCD38 expression
B-CLL1 Untreated Unmutated − 
B-CLL2 Untreated Unmutated − 
B-CLL3 Untreated Unmutated − 
B-CLL4 Treated§ Mutated − − 
B-CLL5 Treated§ Unmutated − 
B-CLL6 Untreated Unmutated 
B-CLL7 Treated§ Unmutated − 
B-CLL8 Treated§ Unmutated − 
B-CLL9 Untreated Mutated − 
B-CLL10 Treated§ Mutated − − 
B-CLL11 Untreated Unmutated − 
B-CLL12 Treated§ Unmutated − 
B-CLL13 Treated§ ND ND ND 
B-CLL14 Treated§ Mutated − 
B-CLL15 Treated§ ND ND ND 
B-CLL16 Treated§ Unmutated 
B-CLL17 Untreated Mutated − 
B-CLL18 Treated§ Unmutated 
B-CLL19 Treated§ Unmutated 
B-CLL20 Treated§ Mutated − − 
B-CLL21 Treated§ Mutated − 
B-CLL22 Treated§ Mutated 
B-CLL23 Treated§ Unmutated − − 
Patient no.Binet stageTreatment statusIgVH mutational status*ZAP-70 expressionCD38 expression
B-CLL1 Untreated Unmutated − 
B-CLL2 Untreated Unmutated − 
B-CLL3 Untreated Unmutated − 
B-CLL4 Treated§ Mutated − − 
B-CLL5 Treated§ Unmutated − 
B-CLL6 Untreated Unmutated 
B-CLL7 Treated§ Unmutated − 
B-CLL8 Treated§ Unmutated − 
B-CLL9 Untreated Mutated − 
B-CLL10 Treated§ Mutated − − 
B-CLL11 Untreated Unmutated − 
B-CLL12 Treated§ Unmutated − 
B-CLL13 Treated§ ND ND ND 
B-CLL14 Treated§ Mutated − 
B-CLL15 Treated§ ND ND ND 
B-CLL16 Treated§ Unmutated 
B-CLL17 Untreated Mutated − 
B-CLL18 Treated§ Unmutated 
B-CLL19 Treated§ Unmutated 
B-CLL20 Treated§ Mutated − − 
B-CLL21 Treated§ Mutated − 
B-CLL22 Treated§ Mutated 
B-CLL23 Treated§ Unmutated − − 

ND indicates not determined.

*

Mutated was defined as having a frequency of mutations > 2% from germline VH.

Positivity refers to detection of > 20% ZAP-70+/CD19+.

Positivity refers to detection of > 20% CD38+/CD19+.

§

Patients had not received treatment for at least 3 months before the study.

Close Modal

or Create an Account

Close Modal
Close Modal